DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,026 filers reported holding DANAHER CORPORATION in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,919,000 | +3.3% | 7,736 | 0.0% | 0.12% | +7.8% |
Q2 2023 | $1,857,000 | -4.8% | 7,736 | 0.0% | 0.12% | -10.8% |
Q1 2023 | $1,950,000 | +5.9% | 7,736 | +11.5% | 0.13% | +3.2% |
Q4 2022 | $1,841,000 | +2.7% | 6,937 | 0.0% | 0.13% | -8.7% |
Q3 2022 | $1,792,000 | +2.1% | 6,937 | +0.2% | 0.14% | +7.8% |
Q2 2022 | $1,756,000 | -9.7% | 6,926 | +4.5% | 0.13% | +4.1% |
Q1 2022 | $1,944,000 | -10.8% | 6,626 | 0.0% | 0.12% | -10.9% |
Q4 2021 | $2,180,000 | +8.1% | 6,626 | 0.0% | 0.14% | -2.1% |
Q3 2021 | $2,017,000 | +14.1% | 6,626 | +0.5% | 0.14% | +13.7% |
Q2 2021 | $1,768,000 | +25.9% | 6,590 | +5.6% | 0.12% | +20.4% |
Q1 2021 | $1,404,000 | +1.0% | 6,240 | -0.3% | 0.10% | -7.2% |
Q4 2020 | $1,390,000 | +1.8% | 6,258 | -1.4% | 0.11% | -8.3% |
Q3 2020 | $1,366,000 | +20.8% | 6,345 | -0.8% | 0.12% | +11.0% |
Q2 2020 | $1,131,000 | +298.2% | 6,398 | +211.6% | 0.11% | +202.8% |
Q1 2020 | $284,000 | -2.4% | 2,053 | +8.3% | 0.04% | +24.1% |
Q4 2019 | $291,000 | +4.3% | 1,895 | -1.8% | 0.03% | 0.0% |
Q3 2019 | $279,000 | -14.4% | 1,930 | -15.5% | 0.03% | -14.7% |
Q2 2019 | $326,000 | – | 2,283 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 345,428 | $39,965,000 | 17.38% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 276,826 | $36,547,000 | 13.04% |
Eos Focused Equity Management, L.P. | 58,266 | $7,692,000 | 9.98% |
Bodenholm Capital AB | 204,595 | $27,011,000 | 9.90% |
CORTLAND ASSOCIATES INC/MO | 446,012 | $58,883,000 | 9.52% |
MIROVA | 128,368 | $16,947,000 | 9.18% |
Flossbach von Storch AG Zurich | 50,275 | $6,637,000 | 8.09% |
Ostrum Asset Management U.S., LLC | 211,464 | $27,917,000 | 7.77% |
Circle Road Advisors LP | 45,446 | $6,000,000 | 6.49% |
Eversept Partners, LP | 158,764 | $20,985,459 | 6.12% |